212 related articles for article (PubMed ID: 36081847)
1. TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM.
Wang J; Qiao S; Liang S; Qian C; Dong Y; Pei M; Wang H; Wan G
Front Mol Biosci; 2022; 9():985434. PubMed ID: 36081847
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
Zhao A; Wang Z; Wang Y; Chen X
Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
[TBL] [Abstract][Full Text] [Related]
4. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
Li C; Shi H
Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
[TBL] [Abstract][Full Text] [Related]
6. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
[No Abstract] [Full Text] [Related]
7. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
[TBL] [Abstract][Full Text] [Related]
8. Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma.
Zhao Y; Wang L; Li X; Jiang J; Ma Y; Guo S; Zhou J; Li Y
Genes Genomics; 2024 Jul; 46(7):785-801. PubMed ID: 38767825
[TBL] [Abstract][Full Text] [Related]
9. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
Front Immunol; 2022; 13():847624. PubMed ID: 35242144
[TBL] [Abstract][Full Text] [Related]
10. Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma.
Xu J; Zhao Y; Sun H; Xiao Q; Ye P
Int J Gen Med; 2021; 14():4639-4651. PubMed ID: 34434056
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
[TBL] [Abstract][Full Text] [Related]
12. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
[TBL] [Abstract][Full Text] [Related]
13. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
Chen Y; Chen X; Wang X
Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
[TBL] [Abstract][Full Text] [Related]
14. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.
Chi H; Peng G; Yang J; Zhang J; Song G; Xie X; Strohmer DF; Lai G; Zhao S; Wang R; Yang F; Tian G
Front Endocrinol (Lausanne); 2022; 13():1056310. PubMed ID: 36568076
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
16. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
17. CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
Shi X; Xia S; Chu Y; Yang N; Zheng J; Chen Q; Fen Z; Jiang Y; Fang S; Lin J
PLoS One; 2021; 16(8):e0255293. PubMed ID: 34370778
[TBL] [Abstract][Full Text] [Related]
18. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
Wang T; Zhang Y; Bai J; Xue Y; Peng Q
BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
Zhao DD; Zhao X; Li WT
Int J Ophthalmol; 2020; 13(7):1046-1053. PubMed ID: 32685390
[TBL] [Abstract][Full Text] [Related]
20. A centrosome-related gene signature for predicting the overall survival of uveal melanoma.
Yu X; Guo X; Li W; Li J
Transl Cancer Res; 2024 Feb; 13(2):771-781. PubMed ID: 38482432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]